Web Stats Provided By Google Analytics

Tuesday, May 14, 2013

Oncolix to raise $5M for clinical trial

CEO Michael Redman told Houston Business Journal the company has already raised more than $11 million that will be used to finance phase I clinical trials for its ovarian cancer drug, Prolanta.

http://www.bizjournals.com/houston/news/2013/05/14/oncolix-to-raise-5m-for-clinical-trial.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_33+%28Health+Insurance+Industry+News%29

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts